Clinical trials: Sickle Cell Retinopathy, open to volunteers
Proliferative Sickle Cell Retinopathy
Anti-VEGF Versus Prompt Laser or Observation for Proliferative Sickle Cell Retinopathy (ALPS)
The purpose of the study is to determine if anti-VEGF/anti-Ang2 therapy results in prevention of vitreous hemorrhage or retinal detachment as compared to localized scatter laser photocoagulation in patients with stage 3…
- Trial name
- ALPS (NCT07922460)
- Testing
- Faricimab Injection for stage 3 or stage 4 Proliferative sickle cell eyes, Vitrectomy, Laser photocoagulation
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of Illinois Chicago